“…For MCRH, because of the frequent failure of cytotoxic and anti-TNF-α drugs and the risk of associated malignant conditions, an interesting complete remission was obtained with anakinra [18]. Similarly, besides local treatment for isolated and/or accessible lesions in XD, several treatment strategies showed disappointing results (or were successful in isolated cases), including lipid-lowering agents, prednisone, interferon-α, immunosuppressants and chemotherapies (table 1) [20,21,22,23,24,25,26,27,28,29,30,31]. The proposal of anakinra therefore appears adequate in our XD patient, by analogy with its harmless and successful results in ECD and MCRH, on the basis of histological and biological evidence for the leading role of IL-1 cytokines in these last two NLH [3,18].…”